Cargando…
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study
BACKGROUND: Acid suppression with a proton pump inhibitor is standard treatment for gastroesophageal reflux disease and erosive esophagitis in adults and increasingly is becoming first-line therapy for children aged 1-17 years. We evaluated endoscopic healing of erosive esophagitis with esomeprazole...
Autores principales: | Tolia, Vasundhara, Youssef, Nader N, Gilger, Mark A, Traxler, Barry, Illueca, Marta |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904294/ https://www.ncbi.nlm.nih.gov/pubmed/20540767 http://dx.doi.org/10.1186/1471-2431-10-41 |
Ejemplares similares
-
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
por: Gunasekaran, Thirumazhisai, et al.
Publicado: (2009) -
Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial
por: Umer, Muhammad Rizwan, et al.
Publicado: (2023) -
A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients with Esophageal Reflux Disease
por: Lee, Ju Yup, et al.
Publicado: (2017) -
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
por: Orlando, Roy C, et al.
Publicado: (2010)